Clinical Trials Directory

Trials / Conditions / Immune-Mediated Necrotizing Myopathy

Immune-Mediated Necrotizing Myopathy

9 registered clinical trials studyying Immune-Mediated Necrotizing Myopathy — 3 currently recruiting.

StatusTrialSponsorPhase
RecruitingMIHRA - Patient-Rooted Insights for Shaping Myositis Science (PRISMS)
NCT07374107
Myositis International Health & Research Collaborative Alliance Foundation—
RecruitingRESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Id
NCT06154252
Cabaletta BioPhase 2 / Phase 3
Enrolling By InvitationA Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults Wi
NCT05979441
argenxPhase 3
Active Not RecruitingA Study to Investigate the Efficacy and Safety of Efgartigimod PH20 SC in Adult Participants With Active Idiop
NCT05523167
argenxPhase 2 / Phase 3
WithdrawnMonotherapy IVIG Gamunex-C for HMG-CoA Reductase Auto-Antibody Positive Necrotizing Myopathy Treatment (The MI
NCT04450654
University of WashingtonPhase 2
Active Not RecruitingAdd-on Intravenous Immunoglobulins in Early Myositis
NCT05832034
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)Phase 2 / Phase 3
CompletedHigh-intensity Strength Training in Myositis
NCT04486261
Rigshospitalet, DenmarkN/A
UnknownJuvenile Autoimmune Necrotizing Myopathies
NCT04295785
Central Hospital, Nancy, France—
TerminatedSafety and Efficacy Study of Zilucoplan in Subjects With Immune-Mediated Necrotizing Myopathy
NCT04025632
Ra PharmaceuticalsPhase 2